Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501872 | SCV000595677 | uncertain significance | not specified | 2016-10-13 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001198742 | SCV001369737 | benign | Prader-Willi syndrome | 2018-10-04 | criteria provided, single submitter | clinical testing | This variant was classified as: Benign. The following ACMG criteria were applied in classifying this variant: BS1,BS2. |
Gene |
RCV001729617 | SCV001988825 | benign | not provided | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001729617 | SCV002563226 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | MAGEL2: BS1 |
Labcorp Genetics |
RCV001729617 | SCV003486534 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002524224 | SCV003684694 | likely benign | Inborn genetic diseases | 2021-10-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001729617 | SCV001978739 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729617 | SCV001980271 | likely benign | not provided | no assertion criteria provided | clinical testing |